00:01
Our topic now brings us to
sub-acute and chronic headache.
00:07
Up until now, we’ve
looked at acute headache.
00:09
We’ve closed the
chapter on that.
00:11
Let’s get into chronic
and subacute.
00:13
Migraine, pseudotumor cerebri,
mass lesion, tumor, abscesses,
tension type headache, chronic daily
headache, trigeminal neuralgia.
00:23
All of these extremely
common in our society.
00:27
We need to make sure that
you’re quite well-versed
with how to first identify it, diagnose
it, and management, you’re good to go.
00:36
We'll first take a
look at migraines.
00:38
Unilateral, throbbing, throbbing.
00:42
“Doc, I feel like my head
is throbbing, pulsating.”
Associated nausea and vomiting.
00:49
Typically, unfortunately,
begins in childhood,
adolescence, young patient,
90% of your patients will be
less than 40 years of age.
00:58
Much more common in
females, migraines.
01:01
What about cluster?
Much more common
in males, young.
01:05
Patients generally want
to still lie in the dark
because if they are
exposed to light,
it bothers them.
01:13
Be careful. Differential obviously
here, meningitis, migraine headache.
01:18
Classification: Classic, you have the aura.
01:22
Common, without the aura.
01:27
Migraine variants, maybe there’s
involvement of the eye,
so ophthalmic or retinal,
menstrual,
hemiplegic,
and basilar.
01:37
These are variants.
01:38
Common without aura,
classic with aura.
01:44
All are based on, well, sterile
inflammation of blood vessels.
01:47
Sterile, not infective.
01:49
Note that when we say “sterile inflammation”
in migraines, we are talking about a concept known as
“neurogenic inflammation” and not the typical
inflammatory response you see in other tissues
such as activation of immune cells and/or autoimmunity.
02:06
The neuroinflammation theory in migraines states
that the trigeminal meningeal nociceptors are activated
due to the release of the neuropeptides.
02:16
Substance P and calcitonin gene-related peptide - to be precise.
02:22
Many things can activate the trigeminovascular system leading to sterile neurogenic inflammation.
02:28
The majority of patients with migraines identify at least one trigger.
02:32
Common triggers include emotional stress, hormones, missing meals, weather changes,
insufficient sleep, strong odors, neck pain, bright lights, alcohol, certain foods, and exercise.
Once identified, some of these triggers can be managed or avoided in some cases.
02:49
Classic migraine is accompanied by an aura that precedes or occurs during the headache pain.
About 25% of patients experience auras with migraines, which are visual or other sensory phenomena.
Auras last less than an hour, and can be confused with transient ischemic attacks (TIAs).
03:05
Progression to severe, usually unilateral headache occurs within an hour.
Both classic and common migraine often have associated symptoms of
nausea, vomiting, photophobia or sensitivity to light, and phonophobia or sensitivity to sound.
Common migraine is a migraine headache without aura.
Patients with classic migraines with aura may also sometimes have common migraine without aura.
03:28
Classically, an aura begins as a small area of visual loss, or as flashes or spots of lights.
Some patients report bright lines like “lightning bolts” or other shapes. S
Some patients have auditory auras with tinnitus, noises, or decreased hearing.
Others experience vertigo or other sensory changes such as paresthesias.
Rarely, patients can present with stroke-like symptoms,
and any migraine aura may present like a TIA at first until the headache starts.
03:54
Occasionally, patients will have an aura without a headache,
and these last less than one hour - the same as auras followed by or accompanied by headache.
04:02
Management of your migraine:
Abortive therapy;
triptans, ergotamine,
and caffeine, perhaps,
NSAIDs, IV steroids,
valproate IV, narcotics.
04:16
Newer options include calcitonin-gene related peptide (CGRP) antagonists
and the selective serotonin 1F receptor agonist, lasmiditan.
04:26
Triptans are a big thing here.
04:28
Preventive: Avoid the trigger
such as light, maybe the sounds.
04:32
Treat attacks early if possible.
04:35
Beta-blockers, tricyclics,
antiepileptics even,
and calcium-channel blockers are all
preventive therapies for your migraines.
04:46
Summary of migraine.
04:48
Female.
04:49
Age: Young.
04:51
Most of your patients, 90% less than 40.
04:54
Preventive: As we said, avoid the triggers.
04:57
Your medications that we talked about
earlier, with calcium channel blockers.
05:01
Signs and symptoms:
Unilateral throbbing,
nausea, photophobia.
05:07
But as you said earlier with
common, it could be bilateral.
05:10
Differential: We talked about
tension type, sinusitis.
05:14
Earlier, we talked about temporal
arteritis with acute and mass lesion.
05:18
H and P for sure.
05:20
Image to make sure that rule out
other possible underlying issues.
05:25
The triptan can cause chest pain
and flushing in such patients.
05:29
Look for this.
05:30
And ergotamines that we talked about,
prolonged use can cause gangrene.
05:34
In addition to the triptans and dihydroergotamine, there are other “migraine-specific” agents.
Calcitonin gene-related peptide antagonists work on the therapeutic target in migraine which is CGRP.
They work by affecting the role of CGRP in pain transmission and neurogenic inflammation.
05:52
There are also several monoclonal antibodies that target CGRP and are used in the prevention of migraine.
Botulinum toxin or “Botox” is not effective for the treatment or prevention of acute migraine,
but is used by injection for patients with chronic migraine.